# 12 Week Study of the Safety/Efficacy of Asenapine When Added to Lithium/Valproate in the Treatment of Bipolar Disorder (A7501008 / P05844 / MK-8274-017)

> **NCT00145470** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 326 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Asenapine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00145470
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06-02
- **Primary completion:** 2007-02-28
- **Final completion:** 2007-03-22
- **Target enrollment:** 326 (ACTUAL)
- **Last updated:** 2024-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00145470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00145470, "12 Week Study of the Safety/Efficacy of Asenapine When Added to Lithium/Valproate in the Treatment of Bipolar Disorder (A7501008 / P05844 / MK-8274-017)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00145470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*